State-Federal Dispute Looms on Drug Imports; HHS Calls Pilot Projects 'Illegal, Unsafe'

The Washington Times (Washington, DC), January 2, 2004 | Go to article overview

State-Federal Dispute Looms on Drug Imports; HHS Calls Pilot Projects 'Illegal, Unsafe'


Byline: Amy Fagan, THE WASHINGTON TIMES

More states and cities are pressuring the federal government to allow them to import prescription drugs from Canada, where the drugs are sold cheaper, and a state-federal feud is brewing.

Current law prohibits the practice unless the Food and Drug Administration can guarantee that the drugs coming into the country are safe, which neither the Clinton nor Bush administration has been able to do.

"Twice the conclusion was reached that we could not guarantee the safety ... so therefore [it] could not occur," said Bill Pierce, spokesman for the Department of Health and Human Services, which includes the FDA. "Nothing has changed since that time," he said, implying that the states and cities will not get their way.

Some local and regional leaders have been asking the government to approve limited drug-importation pilot programs. They say the newly passed Medicare law allows HHS to sanction such programs.

Illinois Gov. Rod R. Blagojevich - a strong proponent of purchasing drugs from Canada, where price controls are in place - is one. He formally asked the administration on Dec. 22 to approve a pilot program under which Illinois would buy drugs from Canada for its 230,000-member state worker and retiree health plan.

Illinois spent $340 million last year on drugs for its employees and retirees. The Democratic governor estimates that the state could save $90 million per year under his plan, which would create a list of FDA-approved drugs that could be obtained safely from Canada, and would institute a state-run program to monitor safety.

"Authorizing our pilot program would give HHS and the FDA the opportunity to see how a program like this works," he said. "They could make changes, adjustments and modifications."

The prescription drugs being discussed are manufactured in FDA-approved facilities worldwide but sell for much higher prices in the United States than in Canada and Europe, said a House Republican aide involved in the issue.

But Mr. Pierce said that even if drugs are manufactured in FDA-approved facilities in Canada or elsewhere, the FDA has no way of tracking them through the country and ensuring that they are stored at correct temperatures and not tampered with or otherwise degraded in quality.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

State-Federal Dispute Looms on Drug Imports; HHS Calls Pilot Projects 'Illegal, Unsafe'
Settings

Settings

Typeface
Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.